Search results
Gilead, with approval in sight, shows $4.3B liver disease drug improves outcomes out to 2 years
FierceBiotech· 17 hours agoThe molecule, seladelpar, had already moved the needle in a phase 3 trial by the time Gilead paid...
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
FierceBiotech· 16 hours agoVir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase...
Gilead’s Trodelvy misses goal in bladder cancer study
BioPharma Dive via Yahoo Finance· 6 days agoTreatment didn’t significantly improve overall survival in the trial, a finding that one analyst...
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 2 days agoThese updated data show consistent ORR and provide mature PFS in patients with locally advanced...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via Yahoo News· 6 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 4 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC ...
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal...
Benzinga· 2 days agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival ...
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
BioPharma Dive via Yahoo Finance· 17 hours agoA study abstract shed more light on tirzepatide’s potential in MASH. Elsewhere, Cytokinetics CEO...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
Pharma firm urged to share new ‘game-changer’ HIV drug
Digital Journal· 7 days agoMore than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical...